» Articles » PMID: 23354985

Serum 25-hydroxyvitamin D Levels and Incident Diabetes Mellitus Type 2: a Competing Risk Analysis in a Large Population-based Cohort of Older Adults

Overview
Journal Eur J Epidemiol
Specialty Public Health
Date 2013 Jan 29
PMID 23354985
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Plausible mechanisms of how vitamin D deficiency may contribute to the development of diabetes mellitus have been proposed but longitudinal cohort studies have yielded heterogeneous results. In 7,791 initially diabetes-free participants of a German population-based cohort, aged 50-74 years, adjusted Cox regression models were employed to estimate hazard ratios (HR) with 95 % confidence intervals (CI) for the association of serum 25-hydroxyvitamin D (25(OH)D) quintiles and incident diabetes. Dose-response relationships were assessed with restricted cubic spline curves. Additionally, analyses accounting for the competing risks of diabetes and death were performed. During 8 years of follow-up, 829 study participants developed diabetes. In women, diabetes risk was significantly increased in the lowest 25(OH)D quintile (HR, 1.38; 1.09-1.75) and non-significantly increased in the 2nd quintile (HR, 1.24; 0.98-1.55) compared to women in 25(OH)D quintiles 3-5. The dose-response relationship showed a non-linear inverse association with risk starting to increase at 25(OH)D levels below 70 nmol/L (statistically significant: below 40 nmol/L). In men, 25(OH)D levels were not associated with diabetes incidence. Renal dysfunction was an effect modifier with a more than doubled diabetes risk in 25(OH)D quintile 1 and an about 1.5-fold risk in quintile 2 compared to quintiles 3-5 if subjects had renal dysfunction. The observed associations were not influenced by the competing risk of death. In this large cohort study of older adults, serum 25(OH)D levels were inversely associated with incident diabetes in women but not in men. The association was particularly strong in subjects with renal dysfunction.

Citing Articles

Association of magnesium intake with predicted atherosclerotic lesions and cardiovascular risk in young adults based on PDAY score: a cross-sectional study.

Song Q, Song L, Liu H, Tan H, Yang B, Fan C BMC Public Health. 2024; 24(1):3232.

PMID: 39567969 PMC: 11580479. DOI: 10.1186/s12889-024-20785-2.


Vitamin D and Risk of Incident Type 2 Diabetes in Older Adults: An Updated Systematic Review and Meta-Analysis.

Dominguez L, Veronese N, Marrone E, Di Palermo C, Iommi C, Ruggirello R Nutrients. 2024; 16(11).

PMID: 38892495 PMC: 11173817. DOI: 10.3390/nu16111561.


Vitamin D and Diabetic Kidney Disease.

Huang H, Lin T, Hong Z, Lim L Int J Mol Sci. 2023; 24(4).

PMID: 36835159 PMC: 9960850. DOI: 10.3390/ijms24043751.


The modification of individual factors on association between serum 25(OH)D and incident type 2 diabetes: Results from a prospective cohort study.

Hu Z, Zhi X, Ma Y, Li J, Wang J, Zhu J Front Nutr. 2023; 9:1077734.

PMID: 36643972 PMC: 9835095. DOI: 10.3389/fnut.2022.1077734.


Longitudinal changes in vitamin D concentrations and the association with type 2 diabetes mellitus: the Tromsø Study.

Allaoui G, Rylander C, Fuskevag O, Averina M, Wilsgaard T, Brustad M Acta Diabetol. 2022; 60(2):293-304.

PMID: 36456716 PMC: 9852201. DOI: 10.1007/s00592-022-02001-y.


References
1.
Berry S, Ngo L, Samelson E, Kiel D . Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc. 2010; 58(4):783-7. PMC: 2873048. DOI: 10.1111/j.1532-5415.2010.02767.x. View

2.
Schottker B, Jansen E, Haug U, Schomburg L, Kohrle J, Brenner H . Standardization of misleading immunoassay based 25-hydroxyvitamin D levels with liquid chromatography tandem-mass spectrometry in a large cohort study. PLoS One. 2012; 7(11):e48774. PMC: 3486791. DOI: 10.1371/journal.pone.0048774. View

3.
Schottker B, Ball D, Gellert C, Brenner H . Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev. 2012; 12(2):708-18. DOI: 10.1016/j.arr.2012.02.004. View

4.
Knekt P, Laaksonen M, Mattila C, Harkanen T, Marniemi J, Heliovaara M . Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008; 19(5):666-71. DOI: 10.1097/EDE.0b013e318176b8ad. View

5.
Pittas A, Nelson J, Mitri J, Hillmann W, Garganta C, Nathan D . Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care. 2012; 35(3):565-73. PMC: 3322702. DOI: 10.2337/dc11-1795. View